Aberdeen Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-504,528
Closed -$3.02M 952
2023
Q4
$3.02M Buy
+504,528
New +$3.02M 0.01% 742